Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/12/1999 | CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof |
08/12/1999 | CA2316182A1 Cdnas encoding secreted proteins |
08/12/1999 | CA2285465A1 Strawberry fruit promoters for gene expression |
08/11/1999 | EP0935001A1 Novel vegf-like factors |
08/11/1999 | EP0935000A2 Orphan receptor |
08/11/1999 | EP0934999A1 DNA mutagenesis by random fragmentation and reassembly |
08/11/1999 | EP0934748A2 Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations |
08/11/1999 | EP0934529A1 METHOD TO DETECT $i(DIROFILARIA IMMITIS) INFECTION |
08/11/1999 | EP0934427A1 Rh blood group antigen compositions and methods of use |
08/11/1999 | EP0934425A1 Renilla luciferase and green fluorescent protein fusion genes |
08/11/1999 | EP0934424A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
08/11/1999 | EP0934423A2 Aav-dna helper virus sequences |
08/11/1999 | EP0934420A2 Methods and means relating to quiescent cells and uses thereof |
08/11/1999 | EP0934418A1 Microbial preparation of substances from aromatic metabolism/i |
08/11/1999 | EP0934416A1 Feline polynucleotide vaccine formula |
08/11/1999 | EP0934415A2 Compounds and methods for diagnosis of tuberculosis |
08/11/1999 | EP0934414A1 Interferon related protein hkafe42 |
08/11/1999 | EP0934413A1 Placental-derived prostate growth factors |
08/11/1999 | EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
08/11/1999 | EP0934411A1 Compositions for treating anemia |
08/11/1999 | EP0934410A1 Brain-associated inhibitor of tissue-type plasminogen activator |
08/11/1999 | EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof |
08/11/1999 | EP0934408A1 Nucleic acid encoding ds-cam proteins and products related thereto |
08/11/1999 | EP0934407A1 Polycation-sensing receptor in aquatic species and methods of use thereof |
08/11/1999 | EP0934405A1 Melanoma associated peptide analogues and vaccines against melanoma |
08/11/1999 | EP0934401A1 Fungal gene encoding resistance to the phytotoxin cercosporin |
08/11/1999 | EP0934340A1 Novel compounds |
08/11/1999 | EP0934338A1 Cellular internalization of pigr stalk and associated ligands |
08/11/1999 | EP0934337A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma |
08/11/1999 | EP0934336A1 Novel compounds |
08/11/1999 | EP0934335A1 Novel compounds |
08/11/1999 | EP0934333A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
08/11/1999 | EP0934081A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
08/11/1999 | EP0934072A1 Manufacturing process for the production of purified transferrin |
08/11/1999 | EP0933997A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors |
08/11/1999 | EP0933994A1 Therapeutic and diagnostic applications of perlecan domain i splice variants |
08/11/1999 | EP0871765A4 Determination of cancerous conditions by mage gene expression |
08/11/1999 | EP0835323A4 Modified proteins and methods of their production |
08/11/1999 | EP0821742A4 Phycobilisomes, derivatives, and uses therefor |
08/11/1999 | EP0759032B1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
08/11/1999 | EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
08/11/1999 | EP0755403B1 Method of separating protective components of bordetella pertussis |
08/11/1999 | EP0719281B1 Multiple branch peptide constructions for use against hiv |
08/11/1999 | EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
08/11/1999 | EP0699240B1 Gibbon ape leukemia virus-based retroviral vectors |
08/11/1999 | EP0669937B1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
08/11/1999 | EP0651609B1 Pasteurella multocida toxoid vaccines |
08/11/1999 | EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
08/11/1999 | CN1225723A Immunological process for detecting antibadies directed towards tissue transglutaminase (TTG), use of TTG for diagnostic purposes and therapy control, and oral pharmaceutical agent therewith |
08/11/1999 | CN1225685A Avian polynucleotide vaccine formula for anti birds' disease |
08/11/1999 | CN1225684A Avian polynucleotide vaccine formula for anti pig's diseases |
08/11/1999 | CN1225683A Vasoactive amine binding molecules |
08/11/1999 | CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity |
08/11/1999 | CN1225641A Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e. g. histidine) function |
08/11/1999 | CN1225640A Hodgkin disease associated molecules and uses thereof |
08/11/1999 | CN1225590A Peptides with increased binding affinity for HLA molecules |
08/11/1999 | CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease |
08/10/1999 | US5936503 Controllable inductor |
08/10/1999 | US5936256 Method of preparing a biological material for use in ophthalmology |
08/10/1999 | US5936140 Methods of producing feed by reducing endogenous protein levels in soybean |
08/10/1999 | US5936138 Gene encoding mutant L3T4 protein which facilitates HIV infection and transgenic mouse expressing such protein |
08/10/1999 | US5936092 Fatty acid conjugate containing a disulfide linkage; increased absorption of compounds |
08/10/1999 | US5936078 DNA and protein for the diagnosis and treatment of Alzheimer's disease |
08/10/1999 | US5936068 Liver expressed chemokine-1 |
08/10/1999 | US5936067 Macrophage inflammatory protein variants |
08/10/1999 | US5936066 Recombinant human interleukin-1α |
08/10/1999 | US5936065 CS-1 peptidomimetics, compositions and methods of using the same |
08/10/1999 | US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
08/10/1999 | US5936063 A korean toad, bufo bufo gargarizans, which shows stronger antibacterial and antifungal activities than any other conventional antimicrobial peptides. |
08/10/1999 | US5936061 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
08/10/1999 | US5936035 Comprising fibrillar collagen, a fiber disassembly agent to make nonfibrillar collagen and an activated polymer, e.g. polyoxyethylene glycol to form a covalently bonded collagen-polymer conjugate; surgical adhesions; eye implants |
08/10/1999 | US5935940 Compositions and methods for modulating growth of a tissue in a mammal |
08/10/1999 | US5935936 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
08/10/1999 | US5935935 Adenoviral vectors for treatment of hemophilia |
08/10/1999 | US5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
08/10/1999 | US5935931 Human apoptosis-related calcium-binding protein |
08/10/1999 | US5935930 Antithrombotic materials and methods |
08/10/1999 | US5935928 Modified platelet factor-4 |
08/10/1999 | US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas |
08/10/1999 | US5935926 Platelet aggregation inhibitors |
08/10/1999 | US5935925 Methods of treating migraine and compounds useful for such methods |
08/10/1999 | US5935865 Semaphorin gene family |
08/10/1999 | US5935860 Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia |
08/10/1999 | US5935856 It is known that bfgf is a heparin-binding, multifunctional protein that has until now been recognized primarily for its mitogenic and angiogenic properties. |
08/10/1999 | US5935854 Human amyloid protein precursor homolog and kunitz-type inhibitor |
08/10/1999 | US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo. |
08/10/1999 | US5935851 TPR-containing genes |
08/10/1999 | US5935849 Methods and compositions of growth control for cells encapsulated within bioartificial organs |
08/10/1999 | US5935838 Method of cultivating bacteria proteins that are expressed in a temperature regulated manner |
08/10/1999 | US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase. |
08/10/1999 | US5935824 Protein expression system |
08/10/1999 | US5935823 Inserting randomly synthesized fusion nucleotide sequences into vectors producing library transforming cells, screening expressed fusion proteins for sensitivity to ligands; efficient, simple and reproducible |
08/10/1999 | US5935822 Aggregating lipid layers, forming chimeric oligomers comprised of glucuronidase adhesive linked by transmembrane proteinto desired proteins; bioremediation; biosynthesis; agriculture; medical diagnosis; drug delivery |
08/10/1999 | US5935821 Nucleotide sequence that codes polypeptide anti-idiotype immunoglobulin a ganglioside useful in the suppression of cancer and reduction of recurrence; anticarcinogenic agents |
08/10/1999 | US5935820 Polynucleotides encoding vascular endothelial growth factor 2 |
08/10/1999 | US5935819 Process for producing a pharmaceutical preparation of PDGF-AB |
08/10/1999 | US5935818 Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof |
08/10/1999 | US5935817 Genetic engineering |
08/10/1999 | US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds |
08/10/1999 | US5935815 Culturing genetically engineered cells expressing both a proform of a protein and furin, isolating activated protein form |